MENU
AVBP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ArriVent BioPharma (AVBP) Ownership - Who owns ArriVent BioPharma?
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more
Profile
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
617.05M
P/E Ratio
N/A
Total Cash
218.86M
Projected Growth
N/A
Total Debt
176K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.43
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVBP
Capitalization
617M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
219M
Total Cash/Share
6.43
Total Debt
176K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
258M
P/B Ratio
2.39
Cash Flow
N/A
Earnings
-2.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
13.14
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-94.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.75
Shares Held By Institutions
896M
Shares Outstanding - Current
34M
Total Liabilities
17.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-31.907
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com